We expect that ZEVEX will continue growing its business, while increasing revenues and earnings. TheCompany is in the process of expanding its enteral nutrition delivery business into the European market. There isgreat potential for expansion in the functional capacity testing and musculoskeletal evaluation market, which isthe business of the ZEVEX' JTech Medical Industries subsidiary, and the Company is poised to take advantage ofthat opportunity. ZEVEX' CEO, Dave McNally, is actively seeking profitable product lines and companies forpotential acquisition.We believe that ZEVEX will post earnings of $ 0.46 per share in 2000 and $ 0.57 per share in 2001. ZEVEX'continued expansion of its proprietary businesses will increase revenues and earnings and help to safeguard theCompany from the unpredictable fluctuations that are inherent in the contract manufacturing business. Within itscontract manufacturing business, ZEVEX achieves relatively high margins by focusing on ultrasonic andoptoelectronic technologies. ZEVEX is currently trading at a multiple of 0.6X sales, which is below its peergroup average of 0.9X sales.We believe that ZEVEX has successfully established itself in three different niches within the huge medicaldevice industry. In each of these niches—the enteral nutrition delivery business, the functional capacity testingand musculoskeletal evaluation business, and the contract manufacturing business—the Company has achievedtechnical expertise and is aggressively striving to increase market share. Over the past few years, ZEVEX hasbeen experiencing growth in both earnings and revenues, and we expect this growth to continue. Thus we believethat ZEVEX should trade at 0.9X sales, on par with its peer group, rather than at its current multiple of 0.6X sales,and have set our 15-month target price at $9.25.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Esti